2021
DOI: 10.4236/ijcm.2021.127025
|View full text |Cite
|
Sign up to set email alerts
|

Vascular Fractality and Alimentation of Cancer

Abstract: Background: The basal metabolic rate has a scaling by tumor mass on the exponent of 3/4, while a simple surface-supplied volume of the mass would have a lower exponent, 2/3. The higher exponent can be explained by optimizing the overall energy distribution in the tumor, assuming that the target is four-dimensional. There are two possible ways of approximating the metabolic rate of the malignant tumor: 1) the volume blood-supply remains, but the surface and the length of the vessel network are modified; or 2) a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 66 publications
(51 reference statements)
0
2
0
Order By: Relevance
“…The size of the colonies is also a matter [160,165]. The basal, resting metabolic rate in a unit of the cancer mass prefers the growing mass in suboptimal alimentation [161,166].…”
Section: Fourth Stage Of Cancer Developmentmentioning
confidence: 99%
See 1 more Smart Citation
“…The size of the colonies is also a matter [160,165]. The basal, resting metabolic rate in a unit of the cancer mass prefers the growing mass in suboptimal alimentation [161,166].…”
Section: Fourth Stage Of Cancer Developmentmentioning
confidence: 99%
“…The current is powered by endogenous field strength, forming an "injury current" [164,169], which is an internal rebalancing of the charge distribution, driving wound healing [165,170]. The injury current ignites cellular migration [166,171] and supports the proliferation to heal the wound [167,168,172,173]. The electric field ignites the cell division, and the field strength correlates with its frequency of it [169,174].…”
Section: Fifth Stage Of Cancer Developmentmentioning
confidence: 99%